&Partners’s ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 UCIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
46,513
+1,020
+2% +$34.8K 0.01% 1176
2026
Q1
$1.5M Buy
+45,493
New +$1.38M 0.01% 1064

Other funds holding UCIB

&Partners's UCIB Position: Q2 2026 in Review

&Partners increased its ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 (UCIB) stake by 2.2% in Q2 2026, buying an estimated $34.8K and bringing the position to 46,513 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #1176.

&Partners first reported a position in UCIB in Q1 2026 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold UCIB as of Q2 2026.

  • &Partners held 46,513 shares of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 worth $1.52M as of Q2 2026.
  • &Partners bought 1,020 ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 shares in Q2 2026, an estimated $34.8K.
  • ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 made up 0.01% of &Partners's portfolio in Q2 2026, its #1176 holding.
  • &Partners first reported a position in ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 in Q1 2026 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.